Source: Business Wire December 01, 2017 01:05 AM Eastern Standard Time HYDERABAD, India & PRINCETON, N.J. & MALVERN, Pa.-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius Pharma, LLC, today announced its fifth consecutive, first-cycle NDA approval for the Proprietary Products Group,…...